Literature DB >> 3987163

Tc-99m red blood cell venography in deep venous thrombosis of the lower limb. An overview.

R Lisbona, V Derbekyan, J A Novales-Diaz, C L Rush.   

Abstract

Tc-99m red blood cell venography is a simple and sensitive technique for the diagnosis of deep vein thrombosis of the lower limb. The static high count blood pool images of the deep venous system of the leg are readily interpretable and show good correlation with contrast venography. The advantages and limitations of this technique in the clinical setting are discussed in detail in this review.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3987163     DOI: 10.1097/00003072-198503000-00023

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  5 in total

1.  Imaging of deep venous thrombosis in patients using a radiolabelled anti-D-dimer Fab' fragment (99mTc-DI-DD3B6/22-80B3): results of a phase I trial.

Authors:  David Macfarlane; Angelides Socrates; Paul Eisenberg; George Larcos; Paul Roach; Michael Gerometta; Richard Smart; Wendy Tsui; Andrew M Scott
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-09-18       Impact factor: 9.236

2.  Radionuclide venography vs Tc-99m-RBC equilibrium angiography: a comparative paired study.

Authors:  Z H Oster; H L Atkins; M Trivedi
Journal:  Eur J Nucl Med       Date:  1987

Review 3.  Poor-quality red blood cell labelling with technetium-99m: case report and review of the literature.

Authors:  I Adalet; S Cantez
Journal:  Eur J Nucl Med       Date:  1994-02

4.  Radionuclide venography of lower limbs by subcutaneous injection: comparison with venography by intravenous injection.

Authors:  C C Wu; S B Jong
Journal:  Ann Nucl Med       Date:  1989-11       Impact factor: 2.668

5.  Safety, pharmacokinetic and dosimetry evaluation of the proposed thrombus imaging agent 99mTc-DI-DD-3B6/22-80B3 Fab'.

Authors:  David J Macfarlane; Richard C Smart; Wendy W Tsui; Michael Gerometta; Paul R Eisenberg; Andrew M Scott
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-03-10       Impact factor: 9.236

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.